netFormulary Coventry and Warwickshire Area Prescribing Committee NHS
Formulary  
 Search
 Formulary Chapter 2: Cardiovascular system - Full Chapter
Chapter Links...
 Details...
02.11  Expand sub section  Antifibrinolytic drugs and haemostatics
02.11  Expand sub section  Blood-related products
Albutrepenonacog alfa
View adult BNF View SPC online View childrens BNF
Formulary
Red SO
Treatment and prophylaxis of bleeding in patients with haemophilia B
 
   
Dried prothrombin complex
View adult BNF View SPC online View childrens BNF
Formulary
Red SO
Treatment and prophylaxis of bleeding in deficiency of prothrombin complex coagulation factors and any of the vitamin K dependent coagulation factors
 
   
Factor VIIa recombinant with eptacog alfa
View adult BNF View SPC online View childrens BNF
Formulary
Red SO
Treatment and prophylaxis of haemorrhage in patients with haemophilia A or B with inhibitors to factors VIII or IX, acquired haemophilia, factor VII deficiency, or Glanzmannís thrombasthenia
 
   
Factor VIII Inhibitor Bypassing Fraction
View adult BNF View SPC online View childrens BNF
Formulary
Red SO
Treatment and prophylaxis of haemorrhage in patients with congenital factor VIII deficiency (haemophilia A) and factor VIII inhibitors
Treatment of haemorrhage in non-haemophiliac patients with acquired factor VIII inhibitors
 
   
Factor XIII Fraction, Dried
View adult BNF View SPC online View childrens BNF
Formulary
Red SO
Treatment of congenital Factor XIII deficiency
 
   
Human coagulation factor IX
View adult BNF View SPC online View childrens BNF
Formulary
Red SO
Treatment and prophylaxis of bleeding in haemophilia B
(congenital factor IX deficiency)
 
   
Human coagulation factor VIII, octocog alpha
View adult BNF View SPC online View childrens BNF
Formulary
Red SO
Treatment and prophylaxis of bleeding in patients with haemophilia A
(congenital factor VIII deficiency)
 
   
Human plasma protein
View adult BNF View SPC online View childrens BNF
Formulary
Red SO
Treatment of coagulation factor deficiencies, rapid reversal of oral anticoagulants,haemorrhage treatment during fibrinolytic therapy, therapeutic plasma exchange
 
   
Nonacog alpha Factor IX fraction
View adult BNF View SPC online View childrens BNF
Formulary
Red SO
Treatment and prophylaxis of bleeding in patients with haemophilia B
(congenital factor IX deficiency) 
   
Nonacog gamma
View adult BNF View SPC online View childrens BNF
Formulary
Red SO
Treatment and prophylaxis of bleeding in patients with haemophilia B
 
   
Protein C Concentrate (Ceprotinģ)
View adult BNF View SPC online View childrens BNF
Formulary
Red SO
Treatment and prophylaxis of protein C deficiency
 
   
Susocotog alfa
View adult BNF View SPC online View childrens BNF
Formulary
Red SO
Treatment of bleeding episodes in patients with acquired haemophilia caused by antibodies to Factor VIII
 
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Blueteq
High Cost Drug Approval System

Traffic Light Status Information

Status Description

Preferred

Clinicians are free to prescribe these drugs. They are regarded as cost effective choices which have evidence to support their use.  

Second Line

These drugs should only be prescribed in the scenarios described in the formulary after preferred drug(s) have been ruled out.  

Non Formulary

Non-formulary choice - the vast majority of a patientís needs should be met by use of formulary preferred choices and second line options when appropriate. Therefore the Clinician should only use a non-formularly drug if this can be justified and it is recommended that all such instances are recorded in the patient record.  

Green SA

Specialist Advised Ė Specialists may simply advise a patientís GP to initiate these drugs themselves after they have made an initial assessment. Note: SA drugs can be initiated by the specialist according to patient need and also depending on local commissioning arrangements which may mandate, through the contract between provider and commissioner, that all SA drugs are treated as SI.  

Green SI

Specialist Initiation - These drugs must be initiated, i.e. the first dose prescribed, by the specialist and then may be continued when appropriate by the patientís GP following communication from the specialist.  

Amber SC

Shared Care - Responsibility for prescribing may be transferred from secondary to primary care with the agreement of an individual GP and when agreed shared care arrangements have been established. The specialist MUST stabilize the patient before asking for care to be transferred. Only specialists should initiate these drugs. Prescribing should be transferred to GPs according to an Shared Care Agreement [SCA]   

Red SO

Specialist Only - These drugs are deemed to be not appropriate for prescribing by GPs. Specialists should not ask GPs to prescribe these drugs.   

Black BL

Black Listed Medicines - These drugs are considered inappropriate for prescribing in Coventry & Warwickshire as they are either not cost-effective or of proven benefit or both.   

Not Recommended

Not Recommended - These are specialist drugs that are not recommended for use.  

netFormulary